Literature DB >> 17718180

Manipulated data in Shell's Benzene Historical Exposure Study.

David Egilman1, Lerin Kol, Lea Anne Hegg, Susanna Rankin Bohme.   

Abstract

In 1983, in the face of mounting evidence of excess leukemia among workers at Shell Oil's Wood River (IL) and Deer Park (TX) petroleum refineries, Shell initiated the Benzene Historical Exposure Study (BHES). Shell's prior research had implicated occupational exposure to benzene as the source of the excess leukemia. The BHES report submission, which ultimately found no link between exposure and the excess morbidity, coincided with OSHA's planned hearings over a new regulatory standard for benzene. Over the next two decades, Shell published several papers based on or expanding the BHES data, all of which concluded that the excess of leukemia was unrelated to benzene. A review of the raw data on which Shell and its consultants relied reveals that Shell manipulated and omitted data in order to reach conclusions that exculpated it from liability and helped delay stricter benzene regulation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17718180     DOI: 10.1179/oeh.2007.13.2.222

Source DB:  PubMed          Journal:  Int J Occup Environ Health        ISSN: 1077-3525


  4 in total

1.  A new method for scoring financial conflicts of interest.

Authors:  S V M Maharaj
Journal:  Int J Occup Environ Health       Date:  2015

2.  Dust diseases and the legacy of corporate manipulation of science and law.

Authors:  David Egilman; Tess Bird; Caroline Lee
Journal:  Int J Occup Environ Health       Date:  2014-03-04

3.  Talc, Asbestos, and Epidemiology: Corporate Influence and Scientific Incognizance.

Authors:  Triet H Tran; Joan E Steffen; Kate M Clancy; Tess Bird; David S Egilman
Journal:  Epidemiology       Date:  2019-11       Impact factor: 4.822

4.  Scientific integrity: critical issues in environmental health research.

Authors:  Domenico Franco Merlo; Kirsi Vahakangas; Lisbeth E Knudsen
Journal:  Environ Health       Date:  2008-06-05       Impact factor: 5.984

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.